Implication of the Hippo/YAP1 signalling pathway in resistance to chemotherapy across various cancers was highlighted, including GBM and osteosarcoma where it increased resistance to drugs like methotrexate and doxorubicin [12, 47]. This evidence concerns the gene YAP1 and glioblastoma.